Full-Time
Confirmed live in the last 24 hours
Develops AI-optimized AAV vectors for gene therapy
Mid, Senior
Belmont, MA, USA
Strong preference for candidates based in NYC or Greater Boston for occasional in-person engagements.
Dyno Therapeutics focuses on improving gene therapy by creating Adeno-associated virus (AAV) vectors, which are essential for delivering genetic material into cells. Their technology utilizes Artificial Intelligence to design and optimize these vectors, enhancing the effectiveness of gene therapies. Unlike many competitors, Dyno's unique approach combines AI with biotechnology, allowing for tailored solutions that meet the specific needs of pharmaceutical and biotech companies. Their goal is to collaborate with these companies to develop better gene therapies for various diseases, including those affecting muscles, the central nervous system, liver, and eyes.
Company Stage
Series A
Total Funding
$106M
Headquarters
Watertown, Massachusetts
Founded
2018
Help us improve and share your feedback! Did you find this helpful?